JP3878132B2 - 精製活性型ｈｃｖｎｓ２／３プロテアーゼ - Google Patents

精製活性型ｈｃｖｎｓ２／３プロテアーゼ Download PDF

Info

Publication number
JP3878132B2
JP3878132B2 JP2002550090A JP2002550090A JP3878132B2 JP 3878132 B2 JP3878132 B2 JP 3878132B2 JP 2002550090 A JP2002550090 A JP 2002550090A JP 2002550090 A JP2002550090 A JP 2002550090A JP 3878132 B2 JP3878132 B2 JP 3878132B2
Authority
JP
Japan
Prior art keywords
protease
cleavage
amino acid
self
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2002550090A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004514459A (ja
JP2004514459A5 (https=
Inventor
ダイアン シボールト
ダニエル ラマール
ロジャー モーリス
ルイス ピロート
アーニム ポーズ
Original Assignee
ベーリンガー インゲルハイム （カナダ） リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ベーリンガー インゲルハイム （カナダ） リミテッド filed Critical ベーリンガー インゲルハイム （カナダ） リミテッド
Publication of JP2004514459A publication Critical patent/JP2004514459A/ja
Publication of JP2004514459A5 publication Critical patent/JP2004514459A5/ja
Application granted granted Critical
Publication of JP3878132B2 publication Critical patent/JP3878132B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
    • C12N9/506—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses derived from RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Peptides Or Proteins (AREA)
JP2002550090A 2000-12-15 2001-12-13 精製活性型ｈｃｖｎｓ２／３プロテアーゼ Expired - Fee Related JP3878132B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25603100P 2000-12-15 2000-12-15
PCT/CA2001/001796 WO2002048375A2 (en) 2000-12-15 2001-12-13 Purified active hcv ns2/3 protease

Publications (3)

Publication Number Publication Date
JP2004514459A JP2004514459A (ja) 2004-05-20
JP2004514459A5 JP2004514459A5 (https=) 2005-06-23
JP3878132B2 true JP3878132B2 (ja) 2007-02-07

Family

ID=22970839

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002550090A Expired - Fee Related JP3878132B2 (ja) 2000-12-15 2001-12-13 精製活性型ｈｃｖｎｓ２／３プロテアーゼ

Country Status (13)

Country Link
US (4) US6815159B2 (https=)
EP (1) EP1343897B1 (https=)
JP (1) JP3878132B2 (https=)
AT (1) ATE356875T1 (https=)
AU (1) AU2468802A (https=)
CA (1) CA2430661C (https=)
DE (1) DE60127299T2 (https=)
ES (1) ES2282320T3 (https=)
HU (1) HUP0302558A3 (https=)
IL (2) IL155760A0 (https=)
MX (1) MXPA03004835A (https=)
NZ (1) NZ526863A (https=)
WO (1) WO2002048375A2 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0006537D0 (en) * 2000-03-17 2000-05-10 Angeletti P Ist Richerche Bio Assays and screening methods
MXPA03004835A (es) * 2000-12-15 2005-04-19 Boehringer Ingelheim Ltd Proteasa ns2/3 activa, purificada de virus de hepatitis c.
DE10105912A1 (de) * 2001-02-09 2002-08-14 Roche Diagnostics Gmbh Rekombinante Proteinase K
US7785875B2 (en) * 2004-07-03 2010-08-31 Mogam Biotechnology Research Institute Polynucleotide encoding HCV epitopes which can bind to various HLA supertypes, immunogenic composition comprising same and method of inducing an HCV-specific immune response using same
CA2627247C (en) * 2005-10-28 2013-04-02 Boehringer Ingelheim International Gmbh Hepatitis c virus ns2/3 activity assay
US20070141701A1 (en) * 2005-12-21 2007-06-21 Boehringer Ingelheim International Gmbh Hepatitis c virus ns2/3 assay
CN116874555B (zh) * 2023-09-08 2023-11-28 成都华任康生物科技有限公司 一种置换液及其试剂盒和相关应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714371A (en) * 1995-05-12 1998-02-03 Schering Corporation Method for refolding insoluble aggregates of hepatitis C virus protease
IT1277914B1 (it) * 1995-08-22 1997-11-12 Angeletti P Ist Richerche Bio Procedimento per produrre - in forma pura e in quantita' elevate - polipeptidi con l'attivita' proteolitica della proteasi ns3 di hcv, e
WO1999007733A2 (en) 1997-08-11 1999-02-18 Boehringer Ingelheim (Canada) Ltd. Hepatitis c inhibitor peptides
US6280940B1 (en) 1998-08-05 2001-08-28 Agouron Pharmaceuticals, Inc. Reporter gene system for use in cell-based assessment of inhibitors of the Hepatitis C virus protease
WO2001016379A1 (en) 1999-08-30 2001-03-08 Merck & Co., Inc. Hepatitis c virus replication inhibitors
GB0006537D0 (en) * 2000-03-17 2000-05-10 Angeletti P Ist Richerche Bio Assays and screening methods
MXPA03004835A (es) * 2000-12-15 2005-04-19 Boehringer Ingelheim Ltd Proteasa ns2/3 activa, purificada de virus de hepatitis c.

Also Published As

Publication number Publication date
MXPA03004835A (es) 2005-04-19
WO2002048375A3 (en) 2003-02-27
CA2430661C (en) 2010-10-19
JP2004514459A (ja) 2004-05-20
IL155760A0 (en) 2003-12-23
AU2468802A (en) 2002-06-24
ES2282320T3 (es) 2007-10-16
CA2430661A1 (en) 2002-06-20
US20070160629A1 (en) 2007-07-12
ATE356875T1 (de) 2007-04-15
HUP0302558A3 (en) 2012-03-28
US20070172936A1 (en) 2007-07-26
US6815159B2 (en) 2004-11-09
US20040077066A1 (en) 2004-04-22
DE60127299D1 (de) 2007-04-26
US7264811B2 (en) 2007-09-04
IL155760A (en) 2009-02-11
HUP0302558A2 (hu) 2003-10-28
DE60127299T2 (de) 2007-08-30
EP1343897A2 (en) 2003-09-17
WO2002048375A2 (en) 2002-06-20
NZ526863A (en) 2006-06-30
EP1343897B1 (en) 2007-03-14
US20020192640A1 (en) 2002-12-19

Similar Documents

Publication Publication Date Title
Gallinari et al. Multiple enzymatic activities associated with recombinant NS3 protein of hepatitis C virus
JP3280384B2 (ja) Ｃ型肝炎ウイルス（ｈｃｖ）のｎｓ３プロテアーゼの蛋白分解活性のインビトロにおける再生方法
US20090203008A1 (en) Rapid method to determine inhibitor sensitivity of NS3/4A protease sequences cloned from clinical samples
AU2003280239B2 (en) Inhibitor-resistant HCV NS3 protease
Shiryaev et al. Cleavage preference distinguishes the two-component NS2B–NS3 serine proteinases of Dengue and West Nile viruses
Gallinari et al. Modulation of hepatitis C virus NS3 protease and helicase activities through the interaction with NS4A
JPH11512606A (ja) ヘルカーゼ活性および改善された溶解性を有するｈｃｖ ｎｓ３タンパク質フラグメント
US7276373B2 (en) Surrogate cell-based system and method for assaying the activity of hepatitis C virus NS3 protease
US7569374B2 (en) HCV RNA-dependent RNA polymerase
JP3878132B2 (ja) 精製活性型ｈｃｖｎｓ２／３プロテアーゼ
AU2002224688B2 (en) Purified active HCV NS2/3 protease
AU2002224688A1 (en) Purified active HCV NS2/3 protease
EP1945797B1 (en) Hepatitis c virus ns2/3 activity assay
KR0149198B1 (ko) 높은활성을 갖는 재조합된 c형간염바이러스 프로티애즈 및 그 프로티애즈에 대한 저해제 탐색방법
KR20020070125A (ko) 재조합 ｈｃｖ ｎｓ5ｂ 단백질, 및 그의 제조방법 및용도
WO2002010396A9 (en) Gene expression system for mass production of hepatitis c viral rna-dependent rna polymerase and enzyme assay using fusion protein expressed therefrom
JPWO1999043792A1 (ja) ヒトｃ型肝炎ウイルスのｒｎａ依存性ポリメラーゼ活性を有する組換え型タンパク及びその製造方法

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060306

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20060601

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20060608

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060906

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20061002

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20061101

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101110

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111110

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111110

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121110

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121110

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131110

Year of fee payment: 7

LAPS Cancellation because of no payment of annual fees